Cited by 659Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolismIron Metabolism and Disorders

The DOI matches its Crossref record; 345 of the 350 references it cites were found in a registry or an index.

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Open access

Zucca, Fabio A., Segura-Aguilar, Juan, Ferrari, Emanuele, Muñoz, Patricia, Paris, Irmgard, Sulzer, David, Sarna, Tadeusz, Casella, Luigi, Zecca, Luigi·2017·Progress in Neurobiology

DOI 10.1016/j.pneurobio.2015.09.012PMC PMC4826627

Open this paper in CoChat — free account

Abstract

There are several interrelated mechanisms involving iron, dopamine, and neuromelanin in neurons. Neuromelanin accumulates during aging and is the catecholamine-derived pigment of the dopamine neurons of the substantia nigra and norepinephrine neurons of the locus coeruleus, the two neuronal populations most targeted in Parkinson's disease. Many cellular redox reactions rely on iron, however an altered distribution of reactive iron is cytotoxic. In fact, increased levels of iron in the brain of Parkinson's disease patients are present. Dopamine accumulation can induce neuronal death; however, excess dopamine can be removed by converting it into a stable compound like neuromelanin, and this process rescues the cell. Interestingly, the main iron compound in dopamine and norepinephrine neurons is the neuromelanin-iron complex, since neuromelanin is an effective metal chelator. Neuromelanin serves to trap iron and provide neuronal protection from oxidative stress. This equilibrium between iron, dopamine, and neuromelanin is crucial for cell homeostasis and in some cellular circumstances can be disrupted. Indeed, when neuromelanin-containing organelles accumulate high load of toxins and iron during aging a neurodegenerative process can be triggered. In addition, neuromelanin released by degenerating neurons activates microglia and the latter cause neurons death with further release of neuromelanin, then starting a self-propelling mechanism of neuroinflammation and neurodegeneration. Considering the above issues, age-related accumulation of neuromelanin in dopamine neurons shows an interesting link between aging and neurodegeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2015.09.012

Cites

345 of 345 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Self-citation
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854

Show all 350 references

Research works printed but not linked: 1

Inoue, 1984, Chemical analysis of melanin in Guinea pig inner ear, Ear Res. Japan, 16, 68

Sorted by citations

Items 101–200 of 657

Ascorbate and ferritin interactions: Consequences for iron release in vitro and in vivo and implications for inflammation
Badu-Boateng, C., & Naftalin, R. J. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.041 · Cited by 71
Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms
Tamtaji, O. R., Reiter, R. J., Alipoor, R., Dadgostar, E., Kouchaki, E., & Asemi, Z. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00720-5 · Cited by 73
Boronic acid sensors with double recognition sites: a review
Bian, Z., Liu, A., Li, Y., Fang, G., Yao, Q., Zhang, G., & Wu, Z. (2019) · The Analyst · doi:10.1039/c9an00741e · Cited by 71
Melanin and Melanin-Like Hybrid Materials in Regenerative Medicine
Cavallini, C., Vitiello, G., Adinolfi, B., Silvestri, B., Armanetti, P., Manini, P., Pezzella, A., d’Ischia, M., Luciani, G., & Menichetti, L. (2020) · Nanomaterials · doi:10.3390/nano10081518 · Cited by 71
Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function
Trujillo, P., Aumann, M. A., & Claassen, D. O. (2023) · Brain · doi:10.1093/brain/awad300 · Cited by 79
Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry
Brammerloh, M., Morawski, M., Friedrich, I., Reinert, T., Lange, C., Pelicon, P., Vavpetič, P., Jankuhn, S., Jäger, C., Alkemade, A., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118255 · Cited by 76
Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism
Kezele, T. G., & Ćurko‐Cofek, B. (2020) · Nutrients · doi:10.3390/nu12092601 · Cited by 78
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role
Zucca, F. A., Capucciati, A., Bellei, C., Sarna, M., Sarna, T., Monzani, E., Casella, L., & Zecca, L. (2023) · IUBMB Life · doi:10.1002/iub.2654 · Cited by 69
Self-citation
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Riederer, P. F., Monoranu, C., Strobel, S., Iordache, T., & Sian‐Hülsmann, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02414-z · Cited by 69
Melanin and neuromelanin binding of drugs and chemicals: toxicological implications
Karlsson, O., & Lindquist, N. G. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1757-0 · Cited by 73
Untangling senescent and damage‐associated microglia in the aging and diseased brain
Ng, P. Y., McNeely, T. L., & Baker, D. J. (2023) · The FEBS Journal · doi:10.1111/febs.16315 · Cited by 68
Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease
Hare, D. J., Cardoso, B. R., Raven, E. P., Double, K. L., Finkelstein, D. I., Szymlek‐Gay, E. A., & Biggs, B. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-016-0004-y · Cited by 68
Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson’s disease
Friedrich, I., Reimann, K., Jankuhn, S., Kirilina, E. P., Stieler, J., Sonntag, M., Meijer, J., Weiskopf, N., Reinert, T., Arendt, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01145-2 · Cited by 70
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano‐secondary ion mass spectrometry
Biesemeier, A., Eibl, O., Eswara, S., Audinot, J., Wirtz, T., Pezzoli, G., Zucca, F. A., Zecca, L., & Schraermeyer, U. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13648 · Cited by 68
Self-citation
A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases
Singh, Y. P., Pandey, A., Vishwakarma, S., & Modi, G. P. (2018) · Molecular Diversity · doi:10.1007/s11030-018-9878-4 · Cited by 69
Bioprocess of Microbial Melanin Production and Isolation
Choi, K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.765110 · Cited by 66
Levels of aqueous humor trace elements in patients with open-angle glaucoma
Hohberger, B., Chaudhri, M. A., Michalke, B., Lucio, M., Nowomiejska, K., Schlötzer-Schrehardt, U. M., Grieb, P., Ręjdak, R., & Jünemann, A. G. M. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.10.003 · Cited by 66
Isometric exercise facilitates attention to salient events in women via the noradrenergic system
Mather, M., Huang, R., Clewett, D., Nielsen, S. E., Velasco, R., Tu, K., Han, S., & Kennedy, B. L. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116560 · Cited by 67
The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration
Moreno-García, A., Kun, A., Calero, M., & Calero, O. (2021) · Antioxidants · doi:10.3390/antiox10010124 · Cited by 66
Dentate nucleus iron deposition is a potential biomarker for tremor‐dominant Parkinson's disease
He, N., Huang, P., Ling, H., Langley, J. A., Liu, C., Ding, B., Huang, J., Xu, H., Zhang, Y., Zhang, Z., et al. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3554 · Cited by 65
Parkinson's disease–related increase of ‐weighted hypointensity in substantia nigra pars compacta
Langley, J. A., Huddleston, D. E., Sedlacik, J., Boelmans, K., & Hu, X. P. (2016) · Movement Disorders · doi:10.1002/mds.26883 · Cited by 64
Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease
Song, N., Wang, J., Jiang, H. F., & Xie, J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.008 · Cited by 63
Polydopamine-Based Nanocomposite as a Biomimetic Antioxidant with a Variety of Enzymatic Activities for Parkinson’s Disease
Wang, W., Zheng, J., Zhou, H., Liu, Q., Jia, L., Zhang, X., Ge, D., Shi, W., & Sun, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c06981 · Cited by 64
The critical role of ferritinophagy in human disease
Liu, M., Kong, N., Zhang, G., Xu, Q. L., Xu, Y. Y., Ke, P., & Liu, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.933732 · Cited by 64
Iron Deposition in Parkinson’s Disease: A Mini-Review
Zeng, W., Cai, J., Zhang, L., & Peng, Q. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01459-4 · Cited by 64
Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson’s disease through AKT/mTOR pathway
Shi, L., Huang, C., Luo, Q., Xia, Y., Liu, W., Zeng, W., Cheng, A., Shi, R., & Zhengli, C. (2020) · Aging · doi:10.18632/aging.103225 · Cited by 64
Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson’s Disease
Fabbri, M., Reimão, S., Carvalho, M., Nunes, R. G., Abreu, D., Guedes, L. C., Bouça‐Machado, R., Lobo, P. P., Godinho, C., Coelho, M. M., et al. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171135 · Cited by 63
"Metal elements and pesticides as risk factors for Parkinson's disease - A review"
Ullah, I., Zhao, L., Yang, H. T., Muhammad, F., Alwayli, D., Wang, X., & Li, H. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.03.009 · Cited by 72
Catatonia: demographic, clinical and laboratory associations
Rogers, J. P., Pollak, T. A., Begum, N., Griffin, A., Carter, B., Pritchard, M., Broadbent, M., Kolliakou, A., Ke, J., Stewart, R. J., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721004402 · Cited by 68
Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease
Liddell, J. R., & White, A. R. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.016 · Cited by 64
Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification
Bjørklund, G., Hofer, T., Nurchi, V. M., & Aaseth, J. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110717 · Cited by 62
A Brief Review on the Neuroprotective Mechanisms of Vitexin
Lima, L. K. F., Pereira, S. K. S., Sousa, R. D. S., Santos, F. P. D. S., Nascimento, A. D. S., Feitosa, C. M., Figuerêdo, J. D. S., Cavalcante, A. D. N., Araújo, E. C. D. C., & Rai, M. (2018) · BioMed Research International · doi:10.1155/2018/4785089 · Cited by 61
Dopamine-related striatal neurophysiology is associated with specialization of frontostriatal reward circuitry through adolescence
Parr, A. C., Calabro, F., Larsen, B., Tervo-Clemmens, B., Elliot, S., Foran, W., Olafsson, V., & Luna, B. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.101997 · Cited by 60
Polydopamine Shell as a Ga 3+ Reservoir for Triggering Gallium–Indium Phase Separation in Eutectic Gallium–Indium Nanoalloys
Xie, W., Allioux, F., Namivandi‐Zangeneh, R., Ghasemian, M. B., Han, J., Rahim, M. A., Tang, J., Yang, J., Mousavi, M., Mayyas, M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c07278 · Cited by 60
Quantitative Susceptibility Mapping Reveals an Association between Brain Iron Load and Depression Severity
Yao, S., Zhong, Y., Xu, Y., Qin, J., Zhang, N., Zhu, X., & Li, Y. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00442 · Cited by 60
Drug Repurposing in Parkinson’s Disease
Athauda, D. S., & Foltynie, T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0548-y · Cited by 59
Therapeutic effect of a histone demethylase inhibitor in Parkinson’s disease
Mu, M., Qian, Z., Yang, S.-X., Rong, K., Yung, W., & Ke, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03105-5 · Cited by 61
Defective NCOA4-dependent ferroptosis in senescent fibroblasts retards diabetic wound healing
Wei, X., Liu, M., Zheng, Z., Yu, S., Huang, L., Ma, J., Gao, Y., Peng, Y., Chen, L., Tan, R., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01437-7 · Cited by 59
Lesion of the Locus Coeruleus Damages Learning and Memory Performance in Paraquat and Maneb-induced Mouse Parkinson’s Disease Model
Hou, L., Sun, F., Sun, W., Zhang, L., & Wang, Q. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.006 · Cited by 62
Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson’s disease
Xie, S., Niu, W., Xu, F., Wang, Y., Hu, S., & Niu, C. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1835899 · Cited by 58
Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration
Angeloni, C., Gatti, M., Prata, C., Hrelia, S., & Maraldi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093299 · Cited by 62
Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
Ferini‐Strambi, L., Carli, G., Casoni, F. M., & Galbiati, A. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00551 · Cited by 57
Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02150-w · Cited by 58
Hydrogen-Bonded Biohybrid Framework-Derived Highly Specific Nanozymes for Biomarker Sensing
Ye, N., Huang, S., Yang, H., Wu, T. S., Tong, L., Zhu, F., Chen, G., & Ouyang, G. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03381 · Cited by 56
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
Nagatsu, T., Nakashima, A., Watanabe, H., Ito, S., Wakamatsu, K., Zucca, F. A., Zecca, L., Youdim, M. B. H., Wulf, M., Riederer, P. F., et al. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02617-6 · Cited by 57
Self-citation
Brain Iron Homeostasis and Mental Disorders
Wu, Q., Ren, Q., Meng, J., Gao, W., & Chang, Y. (2023) · Antioxidants · doi:10.3390/antiox12111997 · Cited by 62
Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease
Barata‐Antunes, S., Teixeira, F. G., Mendes-Pinheiro, B., Domingues, A. V., Vilaça-Faria, H., Marote, A., Silva, D., Sousa, R. A., & Salgado, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103459 · Cited by 56
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
Jellinger, K. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02028-6 · Cited by 58
Interaction of Melanin with Metal Ions Modulates Their Cytotoxic Potential
Sarna, T., Swartz, H. M., & Żądło, A. C. (2021) · Applied Magnetic Resonance · doi:10.1007/s00723-021-01386-3 · Cited by 53
Self-citation
Three‐dimensional neuromelanin‐sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease
Prasad, S., Stezin, A., Lenka, A., George, L., Saini, J. S., Yadav, R., & Pal, P. K. (2018) · European Journal of Neurology · doi:10.1111/ene.13573 · Cited by 53
Quantitative magnetization transfer imaging of the human locus coeruleus
Trujillo, P., Petersen, K. J., Cronin, M. J., Lin, Y., Kang, H., Donahue, M. J., Smith, S. A., & Claassen, D. O. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.049 · Cited by 51
Mechanical sintering-induced conductive flexible self-healing eGaInSn@PDA NDs/TPU composite based on structural design to against liquid metal leakage
Wu, J., Hu, J., Feng, Y., Fan, H., Wang, K., & Deng, Z. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.141400 · Cited by 51
Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson’s Disease and Intervention with Turmeric
van Rensburg, Z. J., Abrahams, S., Bardien, S., & Kenyon, C. P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02516-5 · Cited by 52
Electronic and protonic transport in bio-sourced materials: a new perspective on semiconductivity
Reali, M., Saini, P., & Santato, C. (2020) · Materials Advances · doi:10.1039/d0ma00579g · Cited by 54
Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage
Du, G., Wang, E., Sica, C. T., Chen, H., Jesus, S. D., Lewis, M. M., Kong, L., Connor, J. R., Mailman, R. B., & Huang, X. (2022) · Movement Disorders · doi:10.1002/mds.29062 · Cited by 51
In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's disease
Huddleston, D. E., Langley, J. A., Sedlacik, J., Boelmans, K., Factor, S. A., & Hu, X. P. (2017) · Human Brain Mapping · doi:10.1002/hbm.23547 · Cited by 50
Colorimetric and fluorometric dual-signal determination of dopamine by the use of Cu-Mn-O microcrystals and C-dots
Wang, J., Du, R., Liu, W., Yao, L., Ding, F., Zou, P., Wang, Y., Wang, X., Zhao, Q., & Rao, H. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.03.107 · Cited by 50
Overdosing on iron: Elevated iron and degenerative brain disorders
D’Mello, S. R., & Kindy, M. S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220953065 · Cited by 49
Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping
Li, G., Tong, R. M., Zhang, M., Gillen, K. M., Jiang, W., Du, Y., Wang, Y., & Li, J. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.119923 · Cited by 49
Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
Pisanu, A., Boi, L., Mulas, G., Spiga, S., Fenu, S., & Carta, A. R. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1874-4 · Cited by 49
Parkinson's disease and skin
Niemann, N., Billnitzer, A., & Jankovic, J. J. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.11.017 · Cited by 50
N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease
Mursaleen, L., Noble, B., Chan, S. H. Y., Somavarapu, S., & Zariwala, M. G. (2020) · Antioxidants · doi:10.3390/antiox9070600 · Cited by 51
Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson’s disease and co-localises with Lewy bodies
Pamphlett, R., & Bishop, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262464 · Cited by 48
Specific visualization of neuromelanin-iron complex and ferric iron in the human post-mortem substantia nigra using MR relaxometry at 7T
Lee, H., Baek, S., Chun, S. Y., Lee, J., & Cho, H. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.11.035 · Cited by 47
Potential Role of Heterocyclic Aromatic Amines in Neurodegeneration
Syeda, T., & Cannon, J. R. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00274 · Cited by 46
Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases
Zhang, Y., Li, X., Ren, K., Peng, J., & Luo, X. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101931 · Cited by 46
Parkinson’s Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges
Watanabe, H., Dijkstra, J. M., & Nagatsu, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042009 · Cited by 48
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson’s Disease
Ferrari, E., Capucciati, A., Prada, I., Zucca, F. A., D’Arrigo, G., Pontiroli, D., Bridelli, M. G., Sturini, M., Bubacco, L., Monzani, E., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00231 · Cited by 46
Self-citation
Alpha-synuclein and iron: two keys unlocking Parkinson’s disease
Lingor, P., Carboni, E., & Koch, J. C. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1695-x · Cited by 48
Iron Dysregulation in Parkinson’s Disease: Focused on the Autophagy–Lysosome Pathway
Chen, L., Huang, Y., Cui, J., Song, N., & Xie, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00390 · Cited by 47
Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease
Li, K. R., Avecillas-Chasin, J. M., Nguyen, T. D., Gillen, K. M., Dimov, A., Chang, E., Skudin, C., Kopell, B. H., Wang, Y., & Shtilbans, A. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12957 · Cited by 47
Midbrain gene screening identifies a new mesoaccumbal glutamatergic pathway and a marker for dopamine cells neuroprotected in Parkinson's disease
Viereckel, T., Dumas, S., Smith-Anttila, C. J. A., Vlcek, B., Bimpisidis, Z., Lagerström, M. C., Konradsson-Geuken, Å., & Wallén-Mackenzie, Å. (2016) · Scientific Reports · doi:10.1038/srep35203 · Cited by 45
Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products
Yang, K., Zeng, L., Zeng, J., Deng, Y., Wang, S., Xu, H., He, Q., Yuan, M., Luo, Y., Ge, A., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102063 · Cited by 46
FeTiO3 nanohexagons based electrochemical sensor for the detection of dopamine in presence of uric acid
Aparna, T. K., & Sivasubramanian, R. (2019) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2019.05.073 · Cited by 45
What’s That (Blue) Spot on my MRI? Multimodal Neuroimaging of the Locus Coeruleus in Neurodegenerative Disease
Kelberman, M. A., Keilholz, S. D., & Weinshenker, D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.583421 · Cited by 46
Hydroxytyrosol induces phase II detoxifying enzyme expression and effectively protects dopaminergic cells against dopamine- and 6-hydroxydopamine induced cytotoxicity
Yu, G., Deng, A., Tang, W., Junzhi, M., Yuan, C., & Ma, J. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.03.005 · Cited by 44
Reverse Engineering To Characterize Redox Properties: Revealing Melanin’s Redox Activity through Mediated Electrochemical Probing
Kang, M., Kim, E., Temoçin, Z., Li, J., Dadachova, E., Wang, Z., Panzella, L., Napolitano, A., Bentley, W. E., & Payne, G. F. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b02428 · Cited by 43
Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases
Galgani, A., Lombardo, F. P., Latta, D. D., Martini, N., Bonuccelli, U., Fornai, F., & Giorgi, F. S. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01087-7 · Cited by 47
Distribution of Iron, Copper, Zinc and Cadmium in Glia, Their Influence on Glial Cells and Relationship with Neurodegenerative Diseases
Górska, A., Markiewicz-Gospodarek, A., Markiewicz, R., Chilimoniuk, Z., Borowski, B., Trubalski, M., & Czarnek, K. (2023) · Brain Sciences · doi:10.3390/brainsci13060911 · Cited by 44
The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease
Rodríguez‐Leyva, I., Chi-Ahumada, É., Mejía, M., Castanedo-Cázares, J. P., Eng, W., Saikaly, S. K., Carrizales-Rodríguez, J., Levine, T., Norman, R. A., & Jiménez-Capdeville, M. E. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12494 · Cited by 43
Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
Rentsch, P., Stayte, S., Morris, G. P., & Vissel, B. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0487-7 · Cited by 46
Nutraceuticals: An integrative approach to starve Parkinson’s disease
Lama, A., Pirozzi, C., Avagliano, C., Annunziata, C., Mollica, M. P., Calignano, A., Meli, R., & Raso, G. M. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100037 · Cited by 44
Neuromelanin in parkinsonian disorders: an update
Martín‐Bastida, A., Pietracupa, S., & Piccini, P. P. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1325883 · Cited by 44
Solid-state NMR spectroscopy identifies three classes of lipids in Cryptococcus neoformans melanized cell walls and whole fungal cells
Chrissian, C., Camacho, E., Kelly, J. E., Wang, H., Casadevall, A., & Stark, R. E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015201 · Cited by 41
Recent Development and Applications of Polydopamine in Tissue Repair and Regeneration Biomaterials
Guo, K., Wang, Y., Feng, Z.-X., Lin, X.-Y., Wu, Z.-R., Zhong, X.-C., Zhuang, Z.-M., Zhang, T., Chen, J., & Tan, W.-Q. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s437854 · Cited by 41
Utility of susceptibility-weighted imaging in Parkinson’s disease and atypical Parkinsonian disorders
Wang, Z., Luo, X., & Gao, C. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0064-2 · Cited by 41
Highly sensitive detection of dopamine based on gold nanoflowers enhanced-Tb(III) fluorescence
Li, X., Liu, X., Liu, Y., Gao, R., Wu, X., & Gao, X. (2022) · Talanta · doi:10.1016/j.talanta.2022.123700 · Cited by 40
Impact of aging on animal models of Parkinson's disease
Klæstrup, I. H., Just, M. K., Holm, K. L., Alstrup, A. K. O., Romero‐Ramos, M., Borghammer, P., & Berge, N. V. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.909273 · Cited by 44
Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury
Campos, S. S., Alza, N. P., & Salvador, G. A. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.08.007 · Cited by 40
Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2
Wang, R., Wang, Y., Qu, L., Chen, B., Jiang, H. F., Song, N., & Xie, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.02.016 · Cited by 42
Lactoferrin improves cognitive function and attenuates brain senescence in aged mice
Zheng, J., Xie, Y., Li, F., Zhou, Y., Qi, L., Liu, L., & Chen, Z. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103736 · Cited by 39
Shared perturbations in the metallome and metabolome of Alzheimer’s, Parkinson’s, Huntington’s, and dementia with Lewy bodies: A systematic review
Scholefield, M., Unwin, R. D., & Cooper, G. J. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101152 · Cited by 39
Neuromelanin in Parkinson’s Disease: from Fenton Reaction to Calcium Signaling
Knörle, R. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9804-z · Cited by 39
The Importance of Mitophagy in Maintaining Mitochondrial Function in U373MG Cells. Bafilomycin A1 Restores Aminochrome-Induced Mitochondrial Damage
Huenchuguala, S., Muñoz, P., & Segura‐Aguilar, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00152 · Cited by 38
Self-citation
Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease
Segura‐Aguilar, J., & Huenchuguala, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00106 · Cited by 38
Self-citation
l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease
Billings, J. L., Gordon, S. L., Rawling, T., Doble, P., Bush, A. I., Adlard, P. A., Finkelstein, D. I., & Hare, D. J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14676 · Cited by 38
α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosome
Wang, R., Sun, H., Ren, H., & Wang, G. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1756-9 · Cited by 38
Influence of non-adiabatic effects on linear absorption spectra in the condensed phase: Methylene blue
Dunnett, A., Gowland, D., Isborn, C. M., Chin, A. W., & Zuehlsdorff, T. J. (2021) · The Journal of Chemical Physics · doi:10.1063/5.0062950 · Cited by 39
Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
Lakhani, D. A., Zhou, X., Tao, S., Patel, V. N., Wen, S., Okromelidze, L., Greco, E., Lin, C., Westerhold, E. M., Straub, S., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00631-3 · Cited by 42
Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene
Chumarina, M., Russ, K., Azevedo, C., Heuer, A., Pihl, M., Collin, A., Frostner, E. Å., Elmér, E., Hyttel, P., Cappelletti, G., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0863-7 · Cited by 38

Authors: Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L.
Affiliations: Institute of Biomedical Technologies (IT)
University of Chile (CL)
Universidad Santo Tomás (CL)
Columbia University Irving Medical Center (US)
Jagiellonian University (PL)
University of Pavia (IT)
Corresponding author: Zecca, Luigi
ORCID: Zucca, Fabio A.
Segura-Aguilar, Juan
Ferrari, Emanuele
Muñoz, Patricia
Paris, Irmgard
Sulzer, David
Sarna, Tadeusz
Casella, Luigi
Zecca, Luigi
Venue: Progress in Neurobiology
Publisher: Elsevier BV
Published: 2017-08
Volume: 155
Pages: 96-119
ISSN: 0301-0082 (ISSN-L)
DOI: 10.1016/j.pneurobio.2015.09.012
PMC: PMC4826627
OpenAlex: W1913653254
Cited by: 659
References: 350
Citations by year: 2026: 43 · 2025: 59 · 2024: 58 · 2023: 73 · 2022: 74 · 2021: 72 · 2020: 70 · 2019: 77 · 2018: 53 · 2017: 46
FWCI: 5.75
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Progress in Neurobiology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
Universidad de Chile (submittedVersion, cc-by-nc-nd)
Funders: National Institute on Drug Abuse (P01DA010154, R01DA007418)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords: neuromelanin, iron, dopamine, brain aging, Parkinson's disease, substantia nigra, locus coeruleus, noradrenergic neurons, oxidative stress, metal chelation, neuroinflammation, microglial activation, neurodegeneration, redox homeostasis
MeSH terms: Aging, Animals, Dopamine, Humans, Iron, Melanins, Parkinson Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks